Blackstone Minerals (BSX:AU) has announced Blackstone Secures New Diamond Drill Rig to Advance Mankayan Download the PDF here. This post appeared first on investingnews.com
Investing
-
-
Piche Resources (PR2:AU) has announced Appointment of Managing Director Download the PDF here. This post appeared first on investingnews.com
-
The copper price climbed to a record high of US$5.64 per pound on the COMEX during the second quarter of 2025. The price rise comes on the back of escalating…
-
International Graphite (IG6:AU) has announced Agreement to develop new Expandable Graphite facility Download the PDF here. This post appeared first on investingnews.com
-
International Graphite (IG6:AU) has announced Reinstatement to Quotation Download the PDF here. This post appeared first on investingnews.com
-
Investing
Anteros Metals Initiates Channel Sampling at Havens Steady Following Grant Confirmation and Exploration Permit Approval
by adminAnteros Metals Inc. (CSE: ANT) (‘Anteros’ or the ‘Company’) is pleased to announce the commencement of a trenching and channel sampling program at its wholly-owned, road-accessible Havens Steady VMS Property…
-
Investing
Questcorp Mining Taps National Inflation Association for Marketing & Investor Outreach Campaign
by adminQuestcorp Mining Inc. (CSE: QQQ,OTC:QQCMF) (OTCQB: QQCMF) (FSE: D910) (‘Questcorp’ or the ‘Company’) is excited to announce a strategic engagement with GRA Enterprises LLC, operating as the National Inflation Association…
-
Blackstone Minerals (BSX:AU) has announced Blackstone Completes Share Purchase Plan Download the PDF here. This post appeared first on investingnews.com
-
Investing
Allied Critical Metals Launches Allied USA to Expand Tungsten Import and Distribution Operations, Lists on OTCQB, and Receives DTC Eligibility
by adminAllied Critical Metals Inc. (CSE: ACM,OTC:ACMIF) (OTCQB: ACMIF) (FSE: 0VJ0) (‘Allied’ or the ‘Company’), which is focused on its 100% owned past producing Borralha and Vila Verde tungsten projects in…
-
Investing
Radiopharm Theranostics Receives IND approval from US FDA to Initiate Phase I Therapeutic Clinical Study to target B7H3 with Betabart
by adminLu177-B7H3 monoclonal antibody is first in class targeted radiopharmaceutical in development against the 4lg subtype of B7-H3 On track to initiate first-in-human study of RV-01…